Skip to content

B-DENTAL: what changed

BE 0885.030.572NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€220,577
2024 · €332,507-€111,930
Equity
€905,110
2024 · €1.5m-€593,190
Cash
€391,805
2024 · €286,636+€105,169
Balance sheet total
€1.5m
2024 · €1.8m-€365,314

Largest movements

2024 to 2025
Assets
  • Receivables after one year -€384,088

    no longer reported in 2025; in 2024 it stood at €384,088

  • Cash +€105,169

    up €105,169 (+36.7%), from €286,636 to €391,805

    mainly Receivables after one year (+€384,088) and Net result for the year (+€220,577)

  • Current investments -€100,007

    down €100,007 (-49.7%), from €201,062 to €101,055

  • Receivables within one year +€20,541

    up €20,541 (+8.6%), from €238,910 to €259,451

    of which Trade receivables: +€16,699

Equity and liabilities
  • Profit (loss) carried forward -€332,507

    no longer reported in 2025; in 2024 it stood at €332,507

  • Reserves -€260,683

    down €260,683 (-22.5%), from €1.2m to €898,910

    of which Distributable reserves: -€258,823

  • Trade debts +€186,827

    up €186,827 (+65.9%), from €283,540 to €470,367

  • Accrued charges and deferred income +€40,847

    first reported in 2025, at €40,847

Income statement
  • Gross operating margin -€135,278

    down €135,278 (-19.4%), from €697,354 to €562,076

  • Taxes -€35,613

    down €35,613 (-29.9%), from €119,167 to €83,555

  • Staff costs +€20,921

    up €20,921 (+8.9%), from €236,072 to €256,993

  • Financial charges -€12,099

    down €12,099 (-67.0%), from €18,048 to €5,949

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €332,507
Gross operating margin -€135,278
Staff costs -€20,921
Depreciation +€1,036
Other operating charges -€3,748
Other operating items +€3,234
Financial income -€3,964
Financial charges +€12,099
Taxes +€35,613
Result 2025 €220,577
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€824,929
Investment +€94,007
Financing -€813,767
Cash 2024 €286,636
Net result for the year +€220,577
Depreciation +€7,403
Receivables after one year +€384,088
Stocks and contracts +€6,962
Receivables within one year -€20,541
Smaller working-capital items -€1,234
Trade debts +€186,827
Accrued charges and deferred income +€40,847
Investment in fixed assets (net) -€6,000
Current investments +€100,007
Contributions, distributions and other -€813,767
Cash 2025 €391,805
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,825,908 €1,460,593 -€365,314 -20.0%
Fixed assets 21/28 €25,442 €24,039 -€1,403 -5.5%
Tangible fixed assets 22/27 €25,442 €24,039 -€1,403 -5.5%
Furniture and vehicles 24 €21,393 €21,211 -€182 -0.9%
Other tangible fixed assets 26 €4,049 €2,827 -€1,221 -30.2%
Current assets 29/58 €1,800,466 €1,436,555 -€363,911 -20.2%
Amounts receivable after more than one year 29 €384,088 - -€384,088
Other amounts receivable 291 €384,088 - -€384,088
Stocks and contracts in progress 3 €686,306 €679,345 -€6,962 -1.0%
Stocks 30/36 €686,306 €679,345 -€6,962 -1.0%
Amounts receivable within one year 40/41 €238,910 €259,451 +€20,541 +8.6%
Trade receivables 40 €186,409 €203,108 +€16,699 +9.0%
Other amounts receivable 41 €52,501 €56,343 +€3,842 +7.3%
Current investments 50/53 €201,062 €101,055 -€100,007 -49.7%
Cash at bank and in hand 54/58 €286,636 €391,805 +€105,169 +36.7%
Deferred charges and accrued income 490/1 €3,464 €4,900 +€1,436 +41.5%
Total equity and liabilities 10/49 €1,825,908 €1,460,593 -€365,314 -20.0%
Equity 10/15 €1,498,300 €905,110 -€593,190 -39.6%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,159,593 €898,910 -€260,683 -22.5%
Non-distributable reserves 130/1 €1,860 - -€1,860
Reserves not available under the articles 1311 €1,860 - -€1,860
Distributable reserves 133 €1,157,733 €898,910 -€258,823 -22.4%
Profit (loss) carried forward 14 €332,507 - -€332,507
Amounts payable 17/49 €327,608 €555,484 +€227,876 +69.6%
Amounts payable within one year 42/48 €327,608 €514,637 +€187,029 +57.1%
Trade debts 44 €283,540 €470,367 +€186,827 +65.9%
Suppliers 440/4 €283,540 €470,367 +€186,827 +65.9%
Taxes, remuneration and social security 45 €44,068 €44,270 +€202 +0.5%
Taxes 450/3 €14,644 €14,644 = 0.0%
Remuneration and social security 454/9 €29,424 €29,626 +€202 +0.7%
Accrued charges and deferred income 492/3 - €40,847 +€40,847
Remuneration, social security and pensions 62 €236,072 €256,993 +€20,921 +8.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,439 €7,403 -€1,036 -12.3%
Other operating charges 640/8 €4,407 €8,155 +€3,748 +85.1%
Non-recurring operating charges 66A €3,234 - -€3,234
Gross operating margin 9900 €697,354 €562,076 -€135,278 -19.4%
Operating profit (loss) 9901 €445,202 €289,525 -€155,677 -35.0%
Financial income 75/76B €24,520 €20,556 -€3,964 -16.2%
Recurring financial income 75 €24,520 €20,556 -€3,964 -16.2%
Financial charges 65/66B €18,048 €5,949 -€12,099 -67.0%
Recurring financial charges 65 €18,048 €5,949 -€12,099 -67.0%
Profit (loss) for the period before taxes 9903 €451,674 €304,131 -€147,543 -32.7%
Income taxes 67/77 €119,167 €83,555 -€35,613 -29.9%
Profit (loss) for the period 9904 €332,507 €220,577 -€111,930 -33.7%
Profit (loss) for the period to be appropriated 9905 €332,507 €220,577 -€111,930 -33.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.6m to €2.1m

Midpoint €1.8m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €905,110
Capitalised earnings €2.4m to €3.3m
Indication €1.6m to €2.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€905,110
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€905,110

Capitalised earnings

net result for the year (9904)
2025
€220,577
2024
€332,507
excluding non-recurring income and charges
€335,741
2023
€280,364
excluding non-recurring income and charges
€446,167
2022
€389,647
excluding non-recurring income and charges
€389,586
2021
€301,139
excluding non-recurring income and charges
€301,068
Average result, excluding non-recurring income and charges
€334,162
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.4m / €2.8m / €3.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.